Jones Financial Companies
DNA icon

Jones Financial Companies’s Ginkgo Bioworks DNA Stock Holding History

Jones Financial Companies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Buy
112
+100
+833% +$836 ﹤0.01% 4574
2026
Q1 		$71 Sell
12
-239
-95% -$1.99K ﹤0.01% 4656
2025
Q4 		$2.09K Buy
251
+2
+0.8% +$22 ﹤0.01% 3807
2025
Q3 		$2.86K Hold
249
– – ﹤0.01% 3573
2025
Q2 		$2.36K Buy
+249
New +$1.93K ﹤0.01% 3411
2024
Q4 		– Sell
-25
Closed -$202 – 3438
2024
Q3 		$202 Buy
+25
New +$251 ﹤0.01% 2944

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Jones Financial Companies's DNA Position: Q2 2026 in Review

Jones Financial Companies increased its Ginkgo Bioworks (DNA) stake by 833% in Q2 2026, buying an estimated $836 and bringing the position to 112 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #4574.

Jones Financial Companies first reported a position in DNA in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.86K in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Jones Financial Companies held 112 shares of Ginkgo Bioworks worth $1.15K as of Q2 2026.
  • Jones Financial Companies bought 100 Ginkgo Bioworks shares in Q2 2026, an estimated $836.
  • Ginkgo Bioworks made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4574 holding.
  • Jones Financial Companies first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's Ginkgo Bioworks position peaked at $2.86K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.